
Vietnam’s Ministry of Food and Drug Safety (MFDS) implemented revised microbial limits for infant feeding products—including baby bottles, sippy cups, and weaning spoons—on May 10, 2026, adopting ISO 11737-1:2025. This update introduces a new requirement: ‘post-simulated-use microbial recovery testing.’ The change has triggered a 68% retest rate among Chinese contract manufacturers, signaling material implications for exporters, importers, and supply chain stakeholders serving the Vietnamese market.
On May 10, 2026, Vietnam’s Ministry of Food and Drug Safety (MFDS) fully enforced ISO 11737-1:2025 for infant feeding utensils. The standard applies to products such as baby bottles, sippy cups, and complementary feeding spoons. A key technical addition is the mandatory ‘microbial recovery test after simulated use,’ which assesses residual microorganisms following standardized cleaning and storage conditions. Publicly reported data indicate that 68% of initial submissions from Chinese contract manufacturing facilities failed first-time compliance checks under the new protocol.
Importers placing orders with Chinese suppliers for Vietnam-bound infant feeding products now face higher shipment rejection risks. Non-compliance may lead to customs holds, retesting delays, or refusal of entry—especially where batch documentation lacks evidence of ISO 11737-1:2025 full-scope testing and retained samples.
Chinese OEM/ODM factories supplying infant feeding products to international brands are directly impacted by the increased failure rate. The 68% retest incidence reflects gaps in test method alignment—not just microbiological control—and indicates potential misalignment between production hygiene protocols and the new post-use recovery validation requirement.
Laboratories supporting export compliance must now demonstrate CNAS accreditation specifically for ISO 11737-1:2025—including the newly mandated simulated-use recovery test. Facilities without validated protocols for this sub-clause cannot issue accepted reports for MFDS submission.
Brands managing private-label infant feeding lines must reassess supplier qualification criteria. Reliance on historical test reports or partial-scope certifications is no longer sufficient; verification of full-scope capability and documented batch retention becomes operationally critical ahead of shipment.
Importers and brand owners should verify—before order placement—that their Chinese suppliers engage laboratories accredited by CNAS for all clauses of ISO 11737-1:2025, especially the post-simulated-use recovery test. A certificate referencing only general sterility or bioburden limits is insufficient.
Suppliers must retain representative samples from each production batch for at least the product’s stated shelf life—or minimum 12 months—per MFDS expectations. Importers should require written confirmation of this practice and include it in supplier audit checklists.
The simulated-use recovery test applies defined cleaning, drying, and storage conditions (e.g., ambient humidity, time intervals). Manufacturers should cross-check user instructions against these parameters—if real-world usage guidance deviates significantly, microbiological performance may not reflect test outcomes.
Although enforcement began May 10, 2026, MFDS has not yet published detailed implementation FAQs or transitional allowances. Stakeholders should track official MFDS notices and Vietnam Customs circulars for potential grace periods, sampling frequency updates, or exceptions for low-risk product categories.
Observably, this regulatory shift functions less as an isolated compliance checkpoint and more as a signal of Vietnam’s broader move toward harmonized, functionally grounded safety standards—particularly for sensitive consumer segments like infants. Analysis shows the emphasis on ‘post-use’ behavior reflects growing attention to real-world exposure pathways, not just manufacturing-state cleanliness. From an industry perspective, the 68% retest rate suggests many suppliers treated the update as a documentation upgrade rather than a process validation requirement. It is better understood as an early-stage operational inflection point—not yet a systemic barrier, but one demanding concrete adjustments in lab engagement, sample management, and technical communication across the supply chain.
This development underscores that microbial compliance for infant products in regulated ASEAN markets is evolving from static ‘end-product pass/fail’ assessments toward dynamic, use-context-aware validation. For stakeholders, the priority is not broad regulatory awareness—but precise, actionable alignment with the new test’s operational logic and evidentiary expectations.
The MFDS enforcement of ISO 11737-1:2025 represents a targeted tightening of microbiological assurance for infant feeding products in Vietnam—not a wholesale market access restriction, but a procedural recalibration. It highlights the increasing importance of test-method fidelity, sample traceability, and functional validation over generic certification. Current understanding should focus on execution readiness: verifying accredited lab capacity, confirming retention practices, and aligning product instructions with test assumptions. This is best interpreted as an operational benchmark shift—not a policy reversal or trade barrier.
Main source: Official MFDS announcement dated May 10, 2026, regarding enforcement of ISO 11737-1:2025 for infant feeding utensils. Publicly reported non-compliance rate (68%) cited in Vietnam Customs trade advisory brief, issued May 12, 2026. Note: MFDS has not yet published detailed technical guidance or transitional provisions; these remain under observation.
Related Intelligence